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Abstract Epidemiological studies associate low dietary magne-
sium intake with an increased incidence of ischémie heart disease 
and sudden cardiac death. We have used proton-magnetic 
resonance ( 1H-NMR) techniques and Mg2+-selective electrodes 
to monitor changes in lipid extracts of aortic and cerebrovascular 
smooth muscle as extracellular ionized magnesium ion concen-
tration (|Mg2 +lo) is lowered. We have found that, within the 
pathophysiological range of M g 2 + concentrations, fatty acid 
chain length and double bond content are progressively reduced 
as [Mg 2 + | 0 is lowered. In contrast, the plasmalogen content is 
progressively increased. A concomitant decrease in fatty acid 
chain length and double bonds indicates oxidation of double 
bonds resulting in truncation of the fatty acids. A decrease in 
lipid oxidation in the presence of elevated M g 2 + could contribute 
to the apparent protective role of increased M g 2 + intake on 
vascular function in humans. 
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1. Introduction 
Over the past three decades, an accumulation of epidemio-
logical studies indicates that the low magnesium content in 
drinking water found in areas with soft water and Mg-poor 
soil [1] is associated with high incidences of ischémie heart 
disease ( IHD) and sudden cardiac death (SCD) [2]. At 
present, the average dietary intake of magnesium has declined 
from about 45(L485 mg/day at the turn of the century to 
about 185-260 mg/day for large segments of the Nor th Amer-
ican populat ion [3]. This shortfall in dietary magnesium may 
be significant in the etiology of atherogenesis and cardiovas-
cular disease. The coronary arteries of such patients often 
show deficits of 30-40% in total magnesium content and con-
comitant elevation in Ca 2 + content. Magnesium is the only 
element that has been found to be consistently lowered in 
cardiac muscle of SCD patients [1]. 
Both animal and human studies [1-5] have shown a strong 
relationship between dietary intake of magnesium and athero-
sclerosis. A number of studies now indicate that in the serum 
ionized M g 2 + is appreciably reduced in the serum of patients 
with atherosclerosis, I H D , myocardial infarction, stroke, and 
hypertension, although total magnesium may be normal [6-8]. 
Magnesium salts have been shown to be effective in the clin-
ical treatment of several cardiovascular diseases (e.g. arrhyth-
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mias, hypertension, acute myocardial infarction) and stroke 
[9-11]. In view of this large body of data on magnesium 
and the observation that fatty streaks in intimai smooth 
muscle precede the development of intermediate atherogenic 
lesions [12], we have investigated the effects of levels of ion-
ized M g 2 + found in patients with I H D and stroke [7,8] on the 
lipids of vascular smooth muscle membranes. 
2. Materials and methods 
2.1. Tissue preparation and incubation 
Adult male Wistar rats (16-20 weeks old, 275-325 g) were killed by 
decapitation and exsanguinated. Thoracic aortae were excised and 
immediately placed in normal Krebs-Ringer bicarbonate (NKRB) sol-
ution at room temperature. They were cleaned of blood, loose con-
nective tissue and fat and were cut into rings about 2-3 mm long. The 
endothelium was removed by rubbing with wet filter paper. The com-
position of the NKRB was (in mM): NaCl, 118; KC1, 4.7; KHPO4, 
1.2; MgS04 , 1.2; CaCl2, 2.5; glucose, 10; NaHC0 3 , 25. The ionic 
activity of Mg2+ in sera and in modified NKRB was monitored by ion 
selective electrodes (NOVA Biomédical Corp., MA) as described by 
Altura et al. [7]. MgSÛ4 was added to Krebs-Ringer bicarbonate 
(KRB) solutions so as to obtain final concentrations of 0.17, 0.3, 
0.6, 1.2 and 4.8 mM Mg2+. 
Male mongrel dogs (15 ±3 kg) were anaesthetized with sodium 
pentobarbital (40 mg/kg, i.v.) and sacrificed by bleeding from the 
common femoral arteries. After craniotomy, the brains were removed 
rapidly and placed in normal NKRB at room temperature. Basilar 
and middle cerebral arteries were carefully excised and cleaned of 
arachnoid membranes and blood elements. The vessels were cut into 
small segments about 3-4 mm in length. For intact tissue prepara-
tions, extreme care was taken to avoid damage of endothelial cells. In 
some rings from canine cerebral arteries, however, the lumen of the 
vessels were gently rubbed with a small wire to remove endothelial 
cells. 
2.2. Lipid extraction and lH-NMR 
Total lipid was extracted by a modification of the method of Bligh 
and Dyer [13]. Tissue samples were homogenized in 4 volumes of 
CHC13 :methanol (1:2 v/v). The suspensions were transferred to 15 
ml glass-stoppered centrifuge tubes, using successive 0.3 ml aliquots 
of water and CHC13 to wash the homogenizer. The homogenate and 
wash volumes were combined, vortexed for 1 min, and centrifuged at 
2000 X g for 5 min. The upper aqueous and lower lipid-containing 
phases were separated, the interfacial material was washed twice 
with 0.35 ml volumes of CHC13 and the upper and lower phases 
pooled with the first fractions. The lower CHCI3 phase was washed 
twice with fresh upper phase and taken to dryness under N2. Lipids 
were stored in CHCI3 in the dark at — 35°C under N2. 
One-pulse spectra were taken on a Varian VXR-500 spectrometer 
operating at a proton frequency of 500 MHZ. All spectra were taken 
at 25°C using a 60° pulse, a spectral width of 5000 Hz, a repetition 
time of 10 s and 8K data points. 256 acquisitions were required to 
attain adequate signal/noise ratios. Resonance intensities were meas-
ured as peak areas in fully relaxed spectra. The average number of 
double bonds or vinyl ether linkage per acyl chain and the average 
carbon chain length were determined as indicated in Fig. 1, below. 
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Fig. 1. Typical 500 MHZ 'H-NMR spectra of an extract of total lipids from a 35 mg sample of rat aorta free of endothelial cells. Upper left: 
expanded spectrum of the 5.7 to 5.2 ppm region demonstrating the proton peaks associated with fatty acid double bonds. Upper right: ex-
panded spectrum of the 2.3 to 0.7 ppm region with assignment of the peaks corresponding to the protons of the fatty acid backbone. The 5.7 
to 5.2 ppm region was magnified 10 times compared to the 2.3 to 0.7 ppm region. Representative fatty acid and plasmalogen structures are il-
lustrated in the lower portion. 
3. Results and discussion 
Proton nuclear magnetic resonance ('H-NMR) spectros-
copy was used to quantitate both fatty acid unsaturation 
and the vinyl ether linkage of plasmalogen and to estimate 
average fatty acid chain length in lipid extracts of vascular 
smooth muscle cells incubated in media containing a range 
of extracellular magnesium ion concentrations ([Mg2+]0). 
1 H-NMR is a rapid and comprehensive technique for moni-
toring lipid composition of cells, body fluids and tissues (e.g. 
[14,15]). Fig. 1 illustrates two regions of the 'H-NMR spectra 
of the total lipid extracted from a 35 mg sample of rat aorta 
stripped of endothelial cells. The peaks corresponding to the 
protons of the fatty acid double bonds appear around 5.3 
ppm (Fig. 1, upper left). The protons associated with the fatty 
acid backbone are shown in the 2.5-0.7 ppm region (Fig. 1, 
upper right). The resonances associated with the protons of 
the vinyl ether (a,ß-unsaturated ether) moiety of plasmalogen 
are measurable at 5.90 ppm (region not shown) in extracts of 
as little as 10 mg of dog cerebrovascular smooth muscle cells 
(see ref. [16]). 
Representative fatty acid and plasmalogen structures, the 
assignments of peaks corresponding to fatty acid double 
bonds (5.34 ppm), methyl group protons (0.85 ppm), 
-(CH2)n- protons (1.25 ppm) and protons associated with oth-
er carbons of the fatty acid chain, are indicated in the lower 
portion of Fig. 1. Assignments are based on those published 
by Sze and Jardetzky [14] and confirmed in our laboratory. 
Fatty acid unsaturation and vinyl ether (plasmalogen) content 
were determined using integrated peak intensities of resonan-
ces unique to those moieties. Average carbon chain length was 
determined by dividing the sum of appropriately normalized 
fatty acid proton intensities of the carbons indicated in Fig. 1 
by the normalized proton intensities of the methyl carbon. 
Total serum Mg in humans normally varies between 0.70 
and 0.96 mM, but the free Mg2+, which is of direct biochem-
ical significance in this study, varies between 0.54 and 0.65 
mM, with an average value of 0.6 mM [6-8]. Pathophysiolog-
ical values (from clinical studies) can approach 0.3 mM [7,8]. 
The lowest reported blood free Mg2+ in humans is about 0.24 
mM [7,8,17]. Intravenous infusion with saline solutions con-
taining 4.8 mM Mg2+ is used for certain types of electrolyte 
and anticonvulsive therapy and approaches the total serum 
level of Mg found in women after Mg2+ therapy for eclamp-
sia. For comparison, 31P-NMR spectroscopy and Mag-
FURA-2 measurements indicate intracellular free Mg2+ in 
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several cell types to also be about 0.5-0.6 mM [18-20]. Clin-
ical work-ups almost invariably measure total serum Mg, but 
free Mg2+ can be determined by using either an ion-selective 
electrode or 31P-NMR. In the present study, free ionized 
Mg2+ levels in the culture medium were measured using an 
ion selective electrode (NOVA Biomédical Corp., MA) [7]. 
We found that in vascular smooth muscle cells, both the 
level of fatty acid unsaturation (double bonds) and the aver-
age fatty acid chain length decrease as extracellular Mg2+ is 
lowered from the physiological into the pathophysiological 
range. Fig. 2 shows the correlation between extracellular 
Mg2+ concentration, fatty acid unsaturation and chain length 
of rat aorta smooth muscle lipids. Aortic segments, with en-
dothelial cells removed, were incubated for 18 h in Krebs-
Ringer bicarbonate solution (pH 7.4) containing 0.17, 0.3, 
0.6, 1.2 or 4.8 mM Mg2+, as measured with an ion-selective 
electrode [7]. Within the pathophysiological range found in 
vivo in humans (0.3 to 0.5 mM) there was nearly a two-fold 
decrease in fatty acid unsaturation and 2-3 carbon decrease in 
average chain length. Similar studies were carried out using 
aortic smooth muscle cell cultures as well as segments of dog 
cerebrovascular blood vessels with endothelial cells removed. 
Fig. 3 illustrates the changes in fatty acid unsaturation and 
average fatty acid chain length in cerebrovascular vessels as a 
function of extracellular magnesium ion concentration in the 
range of 0.17 to 1.2 mM. As Mg2+ increased, there was a 2-3 
fold increase in unsaturation and an increase in average chain 
length of about 3 carbons. Thus, both aortic and cerebrovas-
cular smooth muscle cells respond in the same manner as in 
vitro changes in extracellular Mg2+ ion concentration. Similar 
results were obtained with aortic smooth muscle cell cultures 
(data not shown). 
Since the enzymes that form double bonds in fatty acids 
(desaturases) also introduce the double bond in the vinyl ether 
linkage of plasmalogen [21], Mg2+-dependent changes in plas-
malogens were compared with changes in fatty acid unsatura-
tion. Plasmalogens constitute a unique class of N-containing 
phospholipids in which the sn-1 position (outermost carbon of 
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Fig. 2. Changes in fatty acid unsaturation (- o -) and average fatty 
acid chain length (- • -) in rat aorta smooth muscle cell lipids as a 
function of extracellular Mg2+ concentration. Aortic segments free 
of endothelial cells were incubated in Kreb's Ringers bicarbonate 
medium containing the ionized [Mg2+]0 indicated for 18 h as de-
scribed in text. Points represent pooled tissue from 6 animals. 
Mg2+, mM 
Fig. 3. Changes in fatty acid unsaturation (- o -) and average fatty 
acid chain length (- • -) in dog cerebrovascular smooth muscle cell 
lipids as a function of extracellular Mg2+ concentration. Cerebro-
vascular segments free of endothelial cells were incubated in Kreb's 
Ringers bicarbonate medium containing the [Mg2+]0 indicated for 
18 h as described in text. Points represent means ±SD for individual 
tissue samples (JV=3). 
the glycerol backbone) is occupied by a vinyl ether-linked 
fatty alcohol. Fig. 4 compares the per cent change in vinyl 
ether bonds per acyl side chain and the vinyl ether:double 
bond ratio in dog cerebrovascular smooth muscle lipids as a 
function of Mg2+. In contrast to the Mg-dependent increase 
in classical double bonds noted above, the vinyl ether content 
decreases with increasing [Mg2+]0. The ratio of fatty acid 
double bonds to vinyl ether double bonds in cerebrovascular 
cells increased about 5-fold as extracellular Mg2+ was in-
creased from the pathophysiological to the physiological 
range (0.3-0.8 mM). The data suggest that different desatur-
ases must be involved in the synthesis of plasmalogens and 
unsaturated fatty acids, although one cannot rule out the 
possibility that Mg2+ has different effects on the same enzyme 
acting on different substrates. Since plasmalogens are high in 
excitable and contractile tissue (reviewed in [22]), the in-
creased contractility of vascular smooth muscle in low Mg2+ 
in vivo [1,8,23] may be facilitated by an increased plasmalogen 
content. 
The Mg2+-dependent changes in fatty acid unsaturation 
and average chain length occurred in medium free of exoge-
nous fatty acids and/or lipids. Thus, the changes seen here are 
due to altered turnover and/or modification of endogenous 
membrane lipids. Recently, low Mg2+ environments have 
been shown to lead to the formation of different types of 
free radicals with peroxidative capabilities in cultured endo-
thelial cells [24], heart [25], and intact rat skeletal muscle and 
lipoproteins [26]. The low Mg2+-induced decrease in both 
fatty acid chain length and in number of double bonds most 
probably reflects free radical oxidation of the double bonds 
and chain shortening in the sn-2 position (middle carbon) of 
the glycerol backbone. This oxidative modification of the 
polyunsaturated fatty acyl residues of membrane phospho-
lipids could generate platelet-activating factor (PAF)-like lip-
ids [27], believed to be associated with leucocyte diapedesis 
[27]. Heery et al. [28] have found that exposure of smooth 
muscle cells to oxidized low density lipoprotein (LDL), which 
194 G.A. Morrill et al.lFEBS Letters 408 (1997) 191-194 
7.5 
| 6.0 H 
lu 
M 4.5 
" 3 0 
o 
■5 1-5 
"5. 
a o.o 
_ i _ 
Cerebrovascular Smooth Muscle 
0.0 
75 
Mgz+, mM 
Fig. 4. Changes in vinyl ether (plasmalogen) content (- o -) and 
the ratio of double bonds:vinyl ether bonds (- • -) as a function of 
extracellular Mg2+ concentration. Points represent means ±SD 
(N=3). See experiment described in Fig. 3. 
produces PAF-like lipids, was mitogenic; this is significant 
since atherogenesis requires mitosis of intimai smooth muscle 
cells. The mitogenic activity reported by Heery et al. was 
blocked by PAF-receptor antagonists [28]. On the other 
hand, Zoeller et al. [29] have shown that an increase in mem-
brane plasmalogen protects photosensitized Chinese hamster 
ovary cells from UV; thus, the increase in plasmalogen seen in 
low [Mg2+]0 (Fig. 4) may represent a possible compensatory 
mechanism against lipid oxidation. 
The role of Mg2+ in maintaining normal contractility has 
been attributed to its ability to maintain Ca2+ homeostasis. 
Experiments with 45Ca2+, molecular fluorescent probes and 
with patch clamps demonstrate that in vascular smooth 
muscle Mg2+ competitively inhibits Ca2+ transport, acting 
as a Ca2+ channel blocker [1]. Much of the protective effect 
of magnesium against cardiovascular disease, stroke and myo-
cardial infarction has been attributed to the ability of this 
divalent cation to act as a vasodilator and a natural calcium 
antagonist [1]. A decrease in extracellular Mg2+ concentration 
results in an increased contractility of vascular smooth muscle 
[1,8,23]. The loss of fatty acid double bonds and decrease in 
fatty acid chain length described here occurs in the same low 
concentrations of [Mg2+]0, found recently in the sera of pa-
tients with IHD and stroke [7,8,17], associated with the in-
creased Ca2+, lipoprotein and macrophage permeability ob-
served in atherosclerotic blood vessels (cit. [12]). These Mg2+-
dependent changes in membrane lipids may link various car-
diovascular disease risk factors (e.g. hypercholesterolemia, hy-
pertension, diabetes mellitus, immune injury, end-stage renal 
disease, prolonged stress), and atherogenesis [12,30,31]. 
In summary, the studies outlined here suggest a novel mech-
anism for Mg2+ action in blood vessels. Fatty acid unsatura-
tion (double bonds) and average fatty acid chain length de-
crease in vascular smooth muscle cells from both aortic and 
cerebrovascular tissue with decreasing concentrations of ex-
tracellular ionized Mg2+. The sharpest rate of change occurs 
within the range bracketing the normal to pathophysiological 
Mg2+ concentrations. Since increased dietary intake of poly-
unsaturated fatty acids is thought to be beneficial to the car-
diovascular system [31], and since epidemiological studies in-
dicate a beneficial function for increased dietary Mg [2-4], 
Mg2+ may function to protect the polyunsaturated fatty acids 
from oxidation and/or to facilitate their incorporation into 
membrane phospholipids. These Mg2+-dependent changes in 
membrane lipids could account in part for the experimentally 
and clinically observed beneficial effects of Mg2+ on the main-
tenance of cardiovascular function [9-11]. 
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